However, given the already elevated cytotoxic potential and pro-inflammatory profile in elderly females [10], systemic IL-2 or IL-15 administration could carry risks, such as immune overstimulation or increased susceptibility to autoimmunity [7, 36]. This evidence concerns the gene IL2 and Autoimmunity.